<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01377558</url>
  </required_header>
  <id_info>
    <org_study_id>Gi-03-2011</org_study_id>
    <nct_id>NCT01377558</nct_id>
  </id_info>
  <brief_title>Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes</brief_title>
  <official_title>Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes - Aerobic Endurance Training Versus Strength Endurance Training Versus Combined Aerobic Endurance and Strength Endurance Training -</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of the study are

        -  to determine which kind of supervised exercise intervention (aerobic endurance training
           versus strength endurance training versus combined aerobic endurance and strength
           endurance training) is more effective in improving the metabolic parameters in typ 2
           diabetes patients

        -  to investigate what kind of intervention is more successful in reduction of concomitant
           diseases and improving quality of life

        -  to assess what kind of intervention induces highest effects in long term persistence of
           these positive changes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Meta-analyses which evaluated the effects of structured exercise programs in patients with
      type 2 diabetes demonstrate that regular physical activity improves glycosylated haemoglobin
      (König et al.: Resistance Exercise and Type 2 Diabetes Mellitus, Deutsche Zeitschrift für
      Sportmedizin Jahrgang 62, Nr. 1 (2011): 5-9). Sigal et al. proved that either aerobic or
      resistance training alone improved glycemic control in type 2 diabetes, but the improvements
      are greatest with combined aerobic and resistance training (Sigal, RJ, et al.: Effects of
      Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes, Ann
      Intern Med. 2007 Sep 18;147(6):357-69).

      Therefore, aim of the current study is to compare the effects of aerobic endurance training
      or resistance endurance training or the combination of aerobic endurance training and
      resistance endurance training in diabetes type 2 patients without any other lifestyle or
      dietary interventions.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c-level (haemoglobin A1c)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in HOMA-Index</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in beta-cell-function</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Measured by OGTT (Oral Glucose Tolerance Test)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting plasma glucose levels</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total cholesterol levels</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HDL-cholesterol levels</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in LDL-cholesterol levels</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in triglyceride levels</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in antidiabetic medications</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Class and dosage of blood-glucose lowering drugs are recorded before, after 3 and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammation markers</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>CrP, blood count, interleukinstatus, cytokinstatus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body weight</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body composition</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by Bio-impedance analysis, waist to hip ratio, range of thigh</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in strength</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by Dr. Wolff Back Check</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of maximum heart rate</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Measured by an incremental exercise test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of peak oxygen uptake</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Measured by an incremental exercise test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of vAT (ventilatory anaerobic threshold)</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Measured by an incremental exercise test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in renal function</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Creatininlevel, Albuminlevel (urine), Telomere length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in concentration</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by d2-test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by questionnaire: SF-12, EQ5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of nutrition</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by questionnaire: FEV, FFQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in voluntary physical activity</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>meassured by pedometer (one week)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of cardiac output by Impedance cardiography</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by Task Force Monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of barorezeptorsensitivity</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>by Task Force Monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in carotid-Intima-Media-Thickness</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in aortic pulse-wave velocity</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in central aortic pressure</measure>
    <time_frame>3 and 6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in endothelial dysfunction</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of parodontitis</measure>
    <time_frame>3 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow up of all parameters mentioned above</measure>
    <time_frame>after 12 months</time_frame>
    <description>Follow up after 12 months (6 months after completing the exercise intervention) without any supervised intervention</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Aerobic endurance training intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic endurance training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strength endurance training intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Strength endurance training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined training intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined aerobic endurance training and strength endurance training intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic endurance training intervention</intervention_name>
    <description>The aerobic endurance training group will use cardiovascular training devices
week 1-4: 15 minutes warm up (group) 15 minutes intervention at 80-100% vAT two times per week
week 5-13: 15 minutes warm up (group) 30 minutes intervention at 95-110% vAT two times per week
week 14-26: 15 minutes warm up (group) 45 minutes intervention at 95-110% vAT two times per week</description>
    <arm_group_label>Aerobic endurance training intervention</arm_group_label>
    <other_name>aerobic endurance training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Strength endurance training intervention</intervention_name>
    <description>The strength endurance training intervention group will perform eight exercises on weight machines (Milon circuit training- 60 seconds activity, 30 seconds break)
week 1-4: 15 minutes warm up (group) 1 session resistance training intensity 3 (Buskies) two times per week
week 5-13: 15 minutes warm up (group) 2 sessions resistance training intensity 5 (Buskies) two times per week
week 14-26: 15 minutes warm up (group) 3 sessions resistance training intensity 5 (Buskies) two times per week</description>
    <arm_group_label>Strength endurance training intervention</arm_group_label>
    <other_name>Strength endurance training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Combined aerobic endurance and strength endurance training</intervention_name>
    <description>week 1-4: 15 minutes warm up (group) 15 minutes intervention at 80-100% vAT once per week and 15 minutes warm up (group) 1 session resistance training intensity 3 (Buskies) once per week
week 5-13: 15 minutes warm up (group) 15 minutes intervention at 95-110% vAT and 1 session resistance training intensity 5 (Buskies) two times per week
week 14-26: 15 minutes warm up (group) 30 minutes intervention at 95-110% vAT and 1 session resistance training intensity 5 (Buskies) once a week and 15 minutes warm up (group) 15 minutes intervention at 95-110% vAT and 2 sessions resistance training intensity 5 (Buskies) once a week</description>
    <arm_group_label>Combined training intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnoses of type 2 diabetes (ADA criteria)

          -  admitted diabetes treatments will be diet and oral hypoglycemic agents

        Exclusion Criteria:

          -  sports intervention &gt;60 minutes per week

          -  medical conditions

          -  preproliferative or proliferative retinopathy

          -  instable coronary heart disease

          -  inability to perform the scheduled physical activity programs

          -  acute clinically significant intercurrent diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andree Hillebrecht, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Giessen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Giessen</name>
      <address>
        <city>Giessen</city>
        <state>Hessen</state>
        <zip>35394</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sportpark Zwickau, Glauchau, Meerane</name>
      <address>
        <city>Zwickau</city>
        <state>Sachsen</state>
        <zip>08056</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2011</study_first_submitted>
  <study_first_submitted_qc>June 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2011</study_first_posted>
  <last_update_submitted>June 22, 2011</last_update_submitted>
  <last_update_submitted_qc>June 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Andree Hillebrecht, Dr. med.</name_title>
    <organization>Department of Sports Medicine Giessen</organization>
  </responsible_party>
  <keyword>aerobic training</keyword>
  <keyword>resistance training</keyword>
  <keyword>combination of aerobic and resistance training</keyword>
  <keyword>diabetes</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>HbA1c</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>inflammation markers</keyword>
  <keyword>Parodontitis</keyword>
  <keyword>Exercise intervention</keyword>
  <keyword>training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

